Corticosteroids Versus Teprotumumab for the Treatment of Thyroid Eye Disease. Does Either Mitigate the Need for Additional Treatments?
Authors' conclusion
TED patients treated with IVMP or teprotumumab had similar overall rates of additional interventions. However, IVMP was associated with greater treatment complexity, requiring more varied medical therapies. Teprotumumab-treated patients typically required fewer additional medical therapies and underwent more surgical interventions as a second-line step, suggesting that teprotumumab may simplify the treatment pathway. These data have important implications for patient education and future assessment of the cost-effectiveness of TED therapies.
Study context
- Population
- Thyroid eye disease (TED) patients treated with intravenous methylprednisolone (IVMP) or teprotumumab; excluded: comorbidities requiring high-dose steroids, prior TED therapy within 6 months, or concurrent TED treatments263 per cohort after propensity score matching (PSM)
- Participants
- 417 vs 308
- Exposure
- Teprotumumab vs IVMP
- Teprotumumabn = 417
- IVMPn = 308reference
- Outcome
- Incidence of additional TED-related interventions
- Follow-up
- 6, 12 and 18 months after a 6-month washout period
Methodological detailspropensity score matching, TriNetX Analytics platform
- Propensity score matching
- TriNetX Analytics platform
Main finding
As reported in the abstract
- No significant differences in incidence of additional TED-related interventions between cohorts
- Propensity score matched
Observational data: associations, not effects.
Secondary outcomes
Additional surgical interventions · 12 months · fewer with IVMP
P = 0.019
Additional surgical interventions · 18 months · fewer with IVMP
P = 0.040
Requiring ≥3 additional treatments, among those needing additional TED interventions
Average number of treatments, among those needing additional TED interventions
- Additional medical therapies · similar percentage
- P = 0.423
Average number of treatments, among those needing additional TED interventions
- IVMP: higher treatment burden and more complex treatment trajectories
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →